In addition, the administration of transthyretin from preeclamptic serum into pregnant IL10−/− mice induced the hallmark symptoms of preeclampsia (hypertension, proteinuria, glomerular endotheliosis, fetal growth restriction [FGR]) whereas, transthyretin from control serum did not17. This evidence concerns the gene TTR and fetal growth restriction.